CEO Price-Gouging AIDS Patients Also Did It To Kid Patients

MI2AZ

Active Member
With kidney disease.

The former hedge fund manager whose pharmaceutical company has come under withering attack for allegations of egregious price-gouging on life-saving medication is the subject of a $65 million lawsuit by his former employer for alleged stock manipulation—and it turns out he once tried a similar price hike scheme with that company. During Martin Shkreli's tenure as CEO of Retrophin—the company that is now suing him—the company increased prices on a decades-old kidney medication by about 20 times its original cost, a move similar to the controversial price increase by his new company reported by the New York Times on Sunday.
 

Good Times Good Times

Active Member
If all members of Congress wore suits with their owners on them (like a NASCAR does sponsors), I wonder how many have literally been purchased by this cat and his minions.
 

WAMO

Spanking His Monkey
JUST WONDERING WHAT HE WOULD SAY IF ALL COMPANIES HE BUYS PRODUCT FROM UP'ED THEIR PRICES 200%.
 

Good Times Good Times

Active Member
JUST WONDERING WHAT HE WOULD SAY IF ALL COMPANIES HE BUYS PRODUCT FROM UP'ED THEIR PRICES 200%.
It's not even just that. There is a difference in raising up life dependent drugs vs a TV or some other material item.

But to your question, from a literal POV, he would still be fine considering he's a pharmaceutical CEO. I would venture to say he's financially stable.
 

MI2AZ

Active Member
He decided to reduce the price.

But it doesn't say how much, just that he is still going to make a profit.

____________________

All of the negative attention may have finally had an effect on Mr Shkreli.

His Twitter account, which had sparred with critics for days, went dark and then Mr Shkreli agreed to lower the price.

"We've agreed to lower the price on Daraprim to a point that is more affordable and is able to allow the company to make a profit, but a very small profit," he told ABC News. "We think these changes will be welcomed."
 

MI2AZ

Active Member
He decided to reduce the price.

All of the negative attention may have finally had an effect on Mr Shkreli.

His Twitter account, which had sparred with critics for days, went dark and then Mr Shkreli agreed to lower the price.

"We've agreed to lower the price on Daraprim to a point that is more affordable and is able to allow the company to make a profit, but a very small profit," he told ABC News. "We think these changes will be welcomed."
 

WAMO

Spanking His Monkey
SORRY GTGT. GUESS I DIDNT MAKE THAT CLEAR. I MEANT PRODUCT HIS COMPANY WOULD PURCHASE TO DO WHAT THEY DO. NOT AT BEST BUY. SORRY.
 

9andaWiggle

Addicted Member
He decided to reduce the price.

But it doesn't say how much, just that he is still going to make a profit.

____________________

All of the negative attention may have finally had an effect on Mr Shkreli.

His Twitter account, which had sparred with critics for days, went dark and then Mr Shkreli agreed to lower the price.

"We've agreed to lower the price on Daraprim to a point that is more affordable and is able to allow the company to make a profit, but a very small profit," he told ABC News. "We think these changes will be welcomed."
He's still the front runner (by a LARGE margin) for dickhead of the week.
 
Top